title: Rowell's syndrome induced by terbinafine.
abstract: Terbinafine, a systemic antifungal commonly prescribed for onychomycosis (fungal infection involving the nails) has been reported to cause various cutaneous adverse effects. We describe an overlap syndrome between cutaneous lupus and erythaema multiforme induced by this medication with a review of other reported cases.
authors.affiliation: Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
authors.forename: Aizuri
authors.initials: A
authors.lastname: Murad
authors.affiliation: Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
authors.forename: Emma
authors.initials: E
authors.lastname: Shudell
authors.affiliation: Department of Histopathology, Mater Misericordiae University Hospital, Dublin, Ireland.
authors.forename: Niall
authors.initials: N
authors.lastname: Mulligan
mesh_terms: D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects*; D002990:Clobetasol / Q000031:analogs & derivatives / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000188:drug therapy; D009281:Naphthalenes / Q000009:adverse effects*; D009824:Ointments; D014009:Onychomycosis / Q000188:drug therapy; D013577:Syndrome; D000077291:Terbinafine; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D003879:Dermatologic Agents; D009281:Naphthalenes; D009824:Ointments; C010893:clobetasone butyrate; D002990:Clobetasol; D000077291:Terbinafine